| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.095 | 0.04 |